Scientists explore the healing effects of Gua Sha therapy on patients with diabetic peripheral neuropathy
04/15/2020 // Evangelyn Rodriguez // Views

In this open-label, randomized controlled study, Chinese researchers examined the effect of gua sha therapy in the treatment of diabetic peripheral neuropathy (DPN). Their results were published in the journal Complementary Therapies in Clinical Practice.

  • A total of 119 subjects were recruited by the researchers, 60 were assigned to the gua sha group and 59 were assigned to the usual care (control) group.
  • The treatment involved 12 consecutive sessions of gua sha that occurred once a week.
  • Outcome measures for the study included Toronto Clinical Scoring System (TCSS), Vibration Perception Threshold (VPT), Ankle Brachial Index (ABI), and fasting plasma glucose (FPG).
  • The researchers reported that after the first cycle of gua sha treatment, they found statistically significant differences between the two groups in terms of the performance of sensory function (VPT) and symptoms of peripheral artery disease (ABI).
  • Total TCSS scores and FPG levels, on the other hand, were not different.
  • At the eighth and 12th week of post-intervention assessment, gua sha therapy significantly reduced the severity of neuropathy symptoms, improved the performance of sensory function, reduced peripheral artery disease and regulated plasma glucose levels.
  • Changes in the mean scores for TCSS, VPT, ABI and plasma glucose levels in the gua sha group were significant from baseline to week 12, suggesting that gua sha therapy induced progressive improvement of DPN symptoms, sensory function peripheral artery disease and blood glucose levels.
  • Both groups reported no serious adverse events.

Based on these findings, the researchers concluded that gua sha therapy is a safe, effective and well-tolerated treatment that reduces DPN symptoms.

Journal Reference:

Xie X, Lu L, Zhou X, Zhong C, Ge G, Huang H, Zhang X, Zeng Y. EFFECT OF GUA SHA THERAPY ON PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY: A RANDOMIZED CONTROLLED TRIAL. Complementary Therapies in Clinical Practice. May 2019;35:348–352. DOI: 10.1016/j.ctcp.2019.03.018

Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Embed article link:
Reprinting this article:
Non-commercial use is permitted with credit to (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.